Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $8.3000 (0%) ($8.3000 - $8.3000) on Wed. Dec. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.33% (three month average) | RSI | 84 | Latest Price | $8.3000(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.8% a day on average for past five trading days. | Weekly Trend | BCRX advances 27.2% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(35%) | Factors Impacting BCRX price | BCRX will decline at least -2.665% in a week (0% probabilities). VIXM(-18%) UUP(-13%) VXX(-8%) TBT(-3%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.665% (StdDev 5.33%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $8.18(1.47%) | 10 Day Moving Average | $7.48(10.96%) | 20 Day Moving Average | $6.14(35.18%) | To recent high | -2.6% | To recent low | 64.8% | Market Cap | $1.464b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |